Systemic Anti-Cancer Therapy Regimen Library
Head and Neck Regimens
Nasopharyngeal Regimens
Published
Name
|
Version
|
Date
|
|---|---|---|
| HN NPC Locally advanced - cARBOplatin chemoradiation followed by cARBOplatin and fluorouracil | 2.0.0 | 19/02/2025 |
| HN NPC Locally advanced - cISplatin [Q1W] chemoradiation | 2.0.0 | 19/02/2025 |
| HN NPC Locally advanced - cISplatin [Q3W] chemoradiation followed by cISplatin and fluorouracil | 1.0.0 | 19/02/2025 |
| HN NPC Locally advanced - gemcitabine and cISplatin induction followed by cISplatin chemoradiation | 1.0.0 | 10/03/2025 |
| HN NPC Metastatic - gemcitabine [Q4W] | 1.0.0 | 19/12/2022 |
| HN NPC Metastatic - gemcitabine and cARBOplatin | 1.0.0 | 02/06/2022 |
| HN NPC Metastatic - gemcitabine and cISplatin | 1.0.0 | 02/06/2022 |
Superseded Regimens
| Name | Version | Date |
|---|---|---|
| HN NPC Locally advanced - gemcitabine and cISplatin followed by cISplatin chemoradiation | 1.0.2 | 20/08/2025 |
Salivary gland Regimens
Published
|
Name
|
Version
|
Date
|
|---|---|---|
| HN SAL Metastatic - CAP [CYCLOPHOSPHamide, DOXOrubicin and cISplatin] | 1.0.0 | 02/06/2022 |
| HN SAL Metastatic - cISplatin and vinORELBine [IV] | 1.0.0 | 02/06/2022 |
| HN SAL Metastatic - cISplatin and vinORELBine [oral] | 1.0.0 | 23/01/2026 |
Squamous cell Regimens
Published
Thyroid Regimens
Published
|
Name
|
Version
|
Date
|
|---|---|---|
| HN THY Locally advanced/Metastatic - daBRAFEnib and tRAMEtinib | 1.0.0 | 23/01/2026 |
| HN THY Metastatic - leNVAtinib | 1.0.0 | 03/06/2022 |